182 related articles for article (PubMed ID: 18839270)
1. Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease.
Mitamura M; Tada Y; Koarada S; Inoue H; Suematsu R; Ohta A; Nagasawa K
Mod Rheumatol; 2009; 19(1):57-63. PubMed ID: 18839270
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
3. Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.
Asano T; Furuya MY; Sato S; Kobayashi H; Watanabe H; Suzuki E; Migita K
BMC Res Notes; 2018 May; 11(1):320. PubMed ID: 29784018
[TBL] [Abstract][Full Text] [Related]
4. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A in the treatment of adult Still's disease.
Shojania K; Chalmers A; Rangno K
J Rheumatol; 1995 Jul; 22(7):1391-2. PubMed ID: 7562781
[TBL] [Abstract][Full Text] [Related]
6. Leukocytapheresis (LCAP) for treating refractory adult-onset Still's disease (AOSD).
Izumi Y; Mori T; Matsuo M; Koga Y; Ohno T; Miyashita T; Sasaki O; Ezaki H; Migita K
Mod Rheumatol; 2012 Jun; 22(3):483-7. PubMed ID: 22020671
[TBL] [Abstract][Full Text] [Related]
7. Severe hyperferritinemia--a clue for severe hepatitis in a patient with adult-onset Still's disease.
Bishara R; Braun-Moscovici Y; Dagan A; Toledano K; Saadi T; Sabo E; Balbir-Gurman A
Clin Rheumatol; 2016 Mar; 35(3):795-800. PubMed ID: 25413736
[TBL] [Abstract][Full Text] [Related]
8. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
11. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset Still's disease: clinical, serological and therapeutic considerations.
Iliou C; Papagoras C; Tsifetaki N; Voulgari PV; Drosos AA
Clin Exp Rheumatol; 2013; 31(1):47-52. PubMed ID: 23010097
[TBL] [Abstract][Full Text] [Related]
13. A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels.
Ohe M; Bohgaki T
Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):213-6. PubMed ID: 26535602
[TBL] [Abstract][Full Text] [Related]
14. A Japanese case of severe refractory adult Still's disease: serum interleukin-18 is a possible marker of the response to low-dose cyclosporin A therapy.
Sawayama Y; Nabeshima S; Taniai H; Furusyo N; Kashiwagi S; Hayashi J
Fukuoka Igaku Zasshi; 2002 Sep; 93(9):189-95. PubMed ID: 12426765
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A in the treatment of adult onset Still's disease.
Marchesoni A; Ceravolo GP; Battafarano N; Rossetti A; Tosi S; Fantini F
J Rheumatol; 1997 Aug; 24(8):1582-7. PubMed ID: 9263155
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
18. A case of refractory adult-onset Still's disease with high serum interleukin-18 levels treated with monitoring of serum levels of cyclosporine.
Horai Y; Koyama A; Miyamura T; Hirata A; Nakamura M; Ando H; Takahama S; Minami R; Yamamoto M; Suematsu E
Fukuoka Igaku Zasshi; 2012 Jan; 103(1):24-8. PubMed ID: 22423500
[TBL] [Abstract][Full Text] [Related]
19. Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients.
Zhu G; Liu G; Liu Y; Xie Q; Shi G
J Clin Rheumatol; 2009 Sep; 15(6):284-8. PubMed ID: 19734733
[TBL] [Abstract][Full Text] [Related]
20. Adult onset Still's disease: experience from a tertiary care rheumatology unit.
Reddy Munagala VV; Misra R; Agarwal V; Lawrence A; Aggarwal A
Int J Rheum Dis; 2012 Dec; 15(6):e136-41. PubMed ID: 23253241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
